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ABSTRACT 
Complement fragment 5a (C5a)–C5a receptor (C5aR) signaling plays an essential role in 
neutrophil innate immunity. Blockade of either the ligand or the receptor improves survival rates 
in experimental sepsis. In the current study, sepsis was induced in rats by cecal ligation/puncture. 
Early in sepsis C5aR content on neutrophils significantly dropped, reached the nadir at 24 h after 
onset of sepsis, and progressively elevated thereafter. Western-blot, RT-PCR, and confocal 
microscopy analyses revealed that the loss and re-expression of C5aR during sepsis might be 
due, at least in part, to the receptor internalization and reconstitution. The reduction and 
reconstitution of C5aR correlate with the loss and restoration of innate immune functions of 
blood neutrophils (chemotaxis and reactive oxygen species production), respectively. 
Quantitative measurements of C5aR on blood neutrophils are highly predictive of survival or 
death during sepsis. These data suggest that neutrophil C5aR content represents an essential 
component of an efficient defense system in sepsis and may serve as a prognostic marker for the 
outcome. 
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ctivation of the complement system is an effective defense mechanism against invading 
microorganisms. However, accumulating evidence indicates that excessive activation 
may lead to compromised host defenses (1). There is strong evidence for complement 
activation both in human sepsis and in septic animals (2–5), as reflected by elevated plasma 
levels of anaphylatoxins, such as C3a, C4a, and C5a. In vivo blockade of C5a has been shown to 
significantly improve survival rates in experimental sepsis (3, 6, 7), indicating that an excessive 
amount of C5a in sepsis exerts harmful effects. Recently, we have obtained evidence that 
excessive production of C5a is associated with the loss of the respiratory burst in neutrophils, 
thymocyte apoptosis, and hemostatic defects in a rat model of CLP-induced sepsis (7–9). C5a 
exerts its effects through C5a receptor (C5aR) (10, 11), which belongs to the rhodopsin family of 
A 
 G-protein-coupled receptors with seven transmembrane segments. C5aR signaling has been 
shown to be pertussis toxin-sensitive as well as pertussis toxin-resistant, depending on the 
different G proteins that couple with the receptor (12–16). C5aR expression was originally 
described on myeloid cells, such as neutrophils (17), eosinophils (10), basophils, and monocytes 
(18, 19). However, there is compelling evidence that C5aR is also present on a variety of non-
myeloid cells in many organs, especially in the lung and the liver (20, 21). It has been noted that 
C5aR levels in tissues are elevated in the setting of inflammation. For instance, in a mouse model 
of CLP-induced sepsis C5aR expression is markedly increased in lung, liver, kidney, and heart, 
associated with up-regulation of C5aR mRNA. In this model, systemic blockade of C5aR with 
anti-C5aR antibody significantly improved survival rates (22). The pathophysiological 
importance of C5aR is reinforced by anti-inflammatory activities of a C5a receptor antagonist in 
reverse-passive Arthus reaction and endotoxic shock in rats (23, 24). 
C5aR is ubiquitously present on a variety of cell types and is especially present in abundance on 
human neutrophils (17). C5aR plays an essential role in E. coli-induced oxidative burst and 
phagocytosis in human neutrophils (25). The fundamental roles of neutrophils in killing invading 
microorganisms are seriously compromised in sepsis (7, 26, 27). This dysfunction has been 
recently linked to defects in C5a-C5aR signaling in neutrophils. During experimental sepsis, 
blood neutrophils have shown a diminished ability to bind C5a, impaired chemotactic responses 
to C5a, and a loss of H2O2 production (7, 28). All these defects can be significantly improved 
after systemic blockade of C5a. In septic patients, a significant loss of C5aR content on blood 
neutrophils has been observed, associated with a marked decrease in C5a-induced chemotaxis 
(29). To elucidate the mechanisms for C5aR alteration and ensuing functional changes during 
sepsis, we monitored the C5aR expression on neutrophils after onset of sepsis. C5aR on 
neutrophils internalized at early stage of sepsis and reconstituted later. In this study, we were 
able to establish, for the first time, a strong linkage between reconstitution of C5aR on 
neutrophils and survival of septic animals, suggesting that C5aR may be a critical component in 
neutrophil action during sepsis, dictating the fate of septic subjects. 
MATERIALS AND METHODS 
Preparation and characterization of antibody against rat C5aR 
A 38-amino acid peptide spanning the N-terminus of the rat C5aR 
(MDPISNDSSEITYDYSDGTPNPDMPADGVYIPKMEPGD) was synthesized using an 
Applied Biosystems (Foster City, CA) 430A peptide synthesizer. The peptide was then coupled 
to keyhole limpet hemocyanin by the glutaraldehyde method and used for the immunization of 
rabbits and the production of immunoreactive anti-sera. Staining of this antibody with blood 
neutrophils resulted in a significant peak shift by flow cytometric analysis, when compared to 
preimmune IgG staining. 
Rat model of cecal ligation and puncture 
Male Long-Evans specific-pathogen-free rats (275-300 mg; Harlan, Indianapolis, IN) were used 
in all studies. Anesthesia was induced by intraperitoneal administration of ketamine (20 mg/100 
mg body wt). After the abdomen was shaved and a topical disinfectant was applied, a 2-cm 
midline incision was made and the cecum was identified and ligated below the ileocecal valve, 
 with care being taken not to occlude the bowel. The cecum was then subjected to a single 
through-and-through perforation with an 18-gauge needle. After the bowel was repositioned, the 
abdominal incision was closed in layers with plain gut surgical suture 4-0 (Ethicon, Inc., 
Somerville, NJ) and metallic clips. Sham animals underwent the same procedure except for cecal 
ligation and puncture. Before and after surgery, animals had unlimited access to food and water. 
Animals receiving anti-C5a antibody treatment were injected intravenously at the time of the 
CLP procedure with 500 µg rabbit anti-rat C5a IgG [against the carboxyl-terminal region; 
purified and characterized as described previously (30)] or with 500 µg of preimmune rabbit 
IgG. 
Flow cytometric analysis 
C5aR content on blood neutrophils was evaluated by indirect immunofluorescence staining of 
whole blood using an established lyse/wash procedure (BD PharMingen, San Diego, CA). Flow 
cytometric analysis was carried out immediately after blood collection. One-hundred microliters 
of rat whole blood were first incubated with 1 µg rat Fc Block (BD Pharmingen) for 15 min and 
then stained with 10 µl of anti-C5aR serum for 30 min at room temperature. After being washed, 
the cells were labeled with Fluorescein Isothiocyanate (FITC)-conjugated goat anti-rabbit IgG 
(1:50) (Biosource Inc., Santa Clarita, CA). Erythrocytes were lysed for 10 min by addition of 1× 
fluorescent activated-substrate conversion (FASC) lysing solution (BD Pharmingen). After being 
washed, the leukocytes were resuspended in a fixation solution (1% paraformaldehyde in PBS 
with 0.1% sodium azide). Granulocytes were gated by the typical forward and side light scatter 
profiles. The same-gated population has been proven to be granulocytes by staining of whole 
blood with a FITC-labeled rat granulocyte marker, HIS48 (BD Pharmingen). It revealed that 
≥90% of gated cells were granulocytes. The cells were analyzed on a flow cytometer (Coulter 
Corp., Miami, FL). 
Isolation of rat blood neutrophils 
Whole blood from rats was drawn into syringes containing the anti-coagulant citrate dextrose 
(ACD; Baxter Health Care, Dearfield, IL). Neutrophils were isolated using Ficoll-Paque gradient 
centrifugation (Pharmacia Biotech, Uppsala, Sweden) and dextran sedimentation. After 
hypotonic lysis of residual RBC, the neutrophils were used for further studies. 
Western blot analysis 
Neutrophils (2×106) were dissolved in 100 µl of 2× Laemmli sample buffer lysis buffer. Thirty 
microliters of whole cell lysate were electrophoresed in a denaturing 10% polyacrylamide gel 
and then transferred to a nitrocellulose membrane. Nonspecific binding sites were blocked with 
TBST (40 mM Tris, pH 7.6; 300 mM NaCl, 0.1% Tween 20), containing 5% nonfat dry milk for 
12 h at 4°C. The membrane was then incubated with anti-rat C5aR serum at a 1:100 dilution. 
After five washes in TBST, the membrane was incubated in a 1:10,000 dilution of horseradish 
peroxidase-conjugated donkey anti-rabbit IgG (Amersham Pharmacia Biotech, Piscataway, NJ). 
The membrane was developed by enhanced chemiluminescence technique according to the 
protocol of the manufacturer (Amersham Pharmacia Biotech). 
 Detection of C5aR mRNA by semiquantitative RT-PCR 
Total RNA was isolated from isolated neutrophils with the Trizol method (Life Technologies 
Inc., Rockville, MD) according to the instructions of the manufacturer. Digestion of any 
contaminating DNA was achieved by treatment of samples with RQ1 RNase-Free DNase 
(Promega Corp., Madison, WI). Reverse transcription was performed with 5 µg RNA using the 
Superscript II RNase H– Reverse Transcriptase (Gibco-BRL; Life Technologies Inc., Grand 
Island, NY) according to the protocol of the manufacturer. PCR was then performed with 
primers for C5aR: 5' primer, 5'-TAT AGT CCT GCC CTC GCT CAT-3'; and 3' primer, 5'-TCA 
CCA CTT TGA GCG TCT TGG-3'. The primers were designed for a 409-bp cDNA 
amplification in the middle region of rat C5aR cDNA (nucleotides 373–781). The primers for the 
"housekeeping" gene GAPDH were 5' primer, 5'-GCC TCG TCT CAT AGA CAA GAT G-3'; 
and 3' primer, 5'-CAG TAG ACT CCA CGA CAT AC-3'. After a "hot-start" for 5 min at 94°C, 
25~35 cycles were used for amplification with a melting temperature of 94°C, an annealing 
temperature of 60°C, and an extending temperature of 72°C, each for 1 min, followed by a final 
extension at 72°C for 8 min. RT-PCR products were confirmed by electrophoresis of samples in 
1.2% agarose gel. In some cases, reverse transcriptase was omitted in order to rule out 
contaminating DNA being responsible for any results. To ensure that DNA was detected within 
the linear part of the amplification curves, PCR was performed using different cycle numbers for 
C5aR and GAPDH primers. Thirty cycles of amplification for C5aR and 25 cycles for GAPDH 
were found to be in the linear range of PCR amplifications. 
Immunocytochemistry and confocal microscopy 
Isolated neutrophils were plated on glass coverslips (Fisher, No.1 thickness) fastened to the 
bottom of punched-out wells of 12-well plates (diameter 22.6 mm). Coverslips were sequentially 
coated with poly-D-lysine and calfskin collagen to promote cell adhesion. The cells were fixed 
with 4% paraformaldehyde followed by a permeablization step with 10% methanol. Nonspecific 
binding sites were blocked with 0.1% gelatin for 20 min and with 4% normal goat serum for 30 
min. The cells were incubated with either anti-C5aR serum (1:10) or preimmune serum (1:10) 
for 2 h on ice. The cells were then washed and incubated with Alexa-488 Fab2 fragment of goat 
anti-rabbit IgG (1:200; Molecular Probes; Eugene, OR). The cells were covered with SlowFade 
solution (Molecular Probes) and visualized using a confocal fluorescence microscope (Zeiss 
LSM 510, Jana, Germany). Both projection view and optical sections were developed 
electronically and processed digitally. Optical scanning and digital processing of the images 
were performed to determine the topographic distribution of the Alexa Fluor-conjugated IgG in 
the cells. 
Chemotaxis assay 
After neutrophil isolation, cells were fluorescein labeled with Calcein AM (Molecular Probes). 
Labeled neutrophils were then loaded into the upper chambers of 96-well chemotaxis 
minichambers (Neuroprobe, Cabin John, MD). Lower chambers were loaded with rat 
recombinant C5a or buffer alone. The upper and lower chambers were separated by a 
polycarbonate membrane of 3-µm porosity (Neuroprobe). Minichambers were incubated for 30 
min at 37°C. Cells that did not migrate were carefully wiped away, and the number of cells that 
migrated through the polycarbonate filters to the lower surface was measured by cytofluorometry 
 (Spectra MAX Gemini XS; Molecular Devices, Sunnyvale, CA). Samples were measured in 
quadruplicates. The ratio between the number of cells that migrated through the membrane in the 
presence of C5a and the buffer is defined as the chemotactic index (31). 
Intracellular reactive oxygen species 
The intracellular formation of reactive oxygen species (ROS) was evaluated by using the 
fluorescent probe CM-H2DCFDA (Molecular Probe). Isolated neutrophils were treated with 100 
nM C5a for 15 min at 37°C, followed by incubation with 10 µM CM-H2DCFDA for 30 min at 
37°C. Fluorescence generation associated with ROS production was measured by 
cytofluorometry (Spectra MAX Gemini XS; Molecular Devices). Buffer controls were run in 
parallel. 
Statistical analysis 
In groups with equal variances, data sets were analyzed using one-way ANOVA, and individual 
group means were then compared with the Student-Newman-Keuls multiple comparison test. In 
groups containing unequal variances, Kruskal-Wallis ANOVA was performed, followed by 
Dunnett’s method for multiple comparisons. All values were expressed as the mean ± SE. 
Significance was assigned where P < 0.05. For percent change between groups, values obtained 
from negative controls were subtracted from each data point. A proportional hazard modeling 
was used to compare survival between treatment groups. Survival analysis was performed with 
SAS 8.0 statistical software (SAS Institute, Cary, NC). 
RESULTS 
C5aR expression on blood neutrophils during sepsis 
As shown in a recent study, C5aR levels on blood neutrophils in septic patients are significantly 
lower than those in healthy donors (29). To understand the dynamics of C5aR expression on 
neutrophils during sepsis, C5aR content on blood neutrophils was quantitatively evaluated by 
flow cytometric analysis 0, 4, 12, 24, 36, and 48 h after the onset of CLP-induced sepsis. Blood 
neutrophils from control animals showed a positive staining with anti-C5aR, whereas very 
limited staining was seen with preimmune serum (Fig.1A). During experimental sepsis, C5aR 
content on blood neutrophils was sharply decreased as early as 4 h after onset of CLP, reaching a 
nadir at 24 h. The intensity of C5aR staining was almost as low as the staining found with 
preimmune serum, suggesting a very low level of C5aR expression on neutrophils at this time 
point. Interestingly, C5aR levels increased progressively thereafter (Fig. 1A). Preimmune serum 
showed no positive staining of neutrophils at the various time points. In vitro studies have 
demonstrated that C5a can rapidly induce C5aR internalization on human neutrophils, which 
cause considerable loss of C5aR content on the cell surface (32, 33). 
Role of C5a in sepsis-induced loss of C5aR content on neutrophils 
To address whether excessive C5a in sepsis contributed to the loss of C5aR content on 
neutrophils, systemic C5a was blocked by an intravenous infusion of 500 µg anti-C5a rabbit IgG 
immediately after the onset of sepsis. A companion group of CLP rats was similarly treated with 
 500 µg preimmune IgG. C5aR content on neutrophils was analyzed 12 h after CLP. Anti-C5a 
treatment preserved C5aR content on neutrophils, resulting in 65% increase (P<0.05) in 
comparison to preimmune IgG treatment (Fig. 1B). 
Internalization and reconstitution of C5aR on neutrophils during sepsis 
In CLP-induced sepsis, C5a expression is markedly enhanced in lung, liver, kidney, and heart in 
a transcription-dependent manner (22). To determine the mechanism by which C5aR content on 
neutrophils is regulated during sepsis, we evaluated C5aR protein and mRNA levels in purified 
neutrophils 0, 24, and 48 h after CLP. Western-blot analysis of whole cell lysates of rat 
neutrophils revealed a band with ~44-kDa position, characteristic of rat C5aR (Fig. 2A). Western 
blotting of the same samples with anti-GAPDH shows equal loading. Densitometric 
quantification of C5aR protein levels revealed that there were no significant changes in C5aR 
protein levels in neutrophils from CLP rats when compared to control neutrophils (n=4). C5aR 
PCR products from 30-cycle amplification and GAPDH PCR products from 25-cycle 
amplification, which have been found to be in the linear range of the amplifying reactions, are 
displayed in Fig. 2B. C5aR mRNA levels showed no differences in blood neutrophils isolated 0, 
24, and 48 h after the onset of sepsis (Fig. 2B). To visualize C5aR changes in neutrophils during 
sepsis, we conducted confocal fluorescence microscopy analysis. As shown in Fig. 2C, in control 
(Ctr) cells C5aR showed a uniform distribution in the cell periphery, indicative of membrane 
staining. In contrast, a diffuse pattern of staining was found in the cytoplasmic compartment in 
24 h CLP neutrophils, accompanied by disappearance of the peripheral cell staining, indicative 
of C5aR internalization. In neutrophils 48 h after CLP, C5aR expression appeared to be in both 
membrane and cytoplasm of cells, suggesting that C5aR reconstitution was occurring. These data 
suggest that C5aR on neutrophils is internalized at the early stages of sepsis and is re-expressed 
thereafter. 
Association of functional changes of neutrophils with C5aR levels on neutrophils 
The level of C5aR has been shown to be related to the functional responses of neutrophils. In 
septic patients, a significant loss of C5aR content on blood neutrophils was associated with a 
marked decrease in C5a-induced chemotaxis (29). To study whether the neutrophil function is 
associated with C5aR levels in sepsis, control neutrophils and cells isolated from rats 24 and 48 h 
after CLP were chosen to represent the three different levels of C5aR expression. We first 
evaluated the effect of phorbol 12-myristate 13-acetate (PMA) on C5aR content on neutrophils, 
as PMA is a strong inducer of C5aR internalization (34). As shown in Fig. 3A, 100 nM PMA 
strongly diminished the C5aR staining on control neutrophils. No further internalization was 
observed when 24 h-CLP neutrophils were treated with PMA. However, significant loss of C5aR 
was found in PMA-treated neutrophils obtained from 48 h-CLP rats (Fig. 3A). As expected, 10 
nM C5a induced a vigorous chemotactic response for control neutrophils with a chemotactic 
index (CI) of 9.05 ± 1.28 (Fig. 3B). C5a chemotaxis was severely impaired for cells from 24 h-
CLP animals (CI=2.62±0.55). Chemotaxis responsiveness was significantly improved in 48 h 
CLP cells in comparison to 24 h-CLP cells (CI=4.95±1.34; P<0.05). Another manifestation of 
functional recovery for 48 h-CLP neutrophils was obtained by assessing C5a-induced ROS 
production in these cells (Fig. 3C). C5a (100 nM) evoked a marked increase in ROS generation 
in control cells. This C5a-induced response was completely lost in 24 h-CLP cells. However, 48 
h-CLP cells showed a statistically significant response to C5a as reflected by ROS formation 
 (Fig. 3C; P<0.05 vs. buffer control). These data indicate that loss in C5aR content on neutrophils 
during sepsis is associated with defective functional responses of neutrophils. 
C5aR levels on neutrophils predicts the lethal outcome of septic animals 
The data above lead us to the speculation that C5aR reconstitution may affect the overall 
outcome of septic animals. To test this hypothesis, we assessed the survival of CLP rats and in 
parallel C5aR levels on blood neutrophils 36 h after CLP. Twenty three out of 37 rats survived 
36 h after CLP (Fig. 4A). Blood samples were taken from these survivors' tail vein for assessing 
C5aR levels on blood neutrophils. Based on the overall median (1.03), we divided these animals 
into two groups: high levels of C5aR group (n=11) and low levels of C5aR group (n=12) (Fig. 
4B). All the animals (n=11; 100%) with higher levels of C5aR survived, whereas only 4 out of 
12 (33%) animals with lower levels of C5aR survived during a 7 day interval (Fig. 4C). The 
difference between the outcomes of these two groups was statistically significant (P=0.001 by 
proportional hazards modeling). Thus, the level of C5aR surface expression 36 h after onset of 
sepsis was positively correlated with the survival of the individual animals. 
DISCUSSION 
In sepsis, the innate immune system is severely impaired, as reflected by excessive inflammatory 
mediator production, complement activation, and functional defects in phagocytic cells (26, 27, 
35, 36). At the late stage of sepsis, neutrophils suffer a "dormant" phase in the sense that the 
major features of neutrophil function including chemotaxis, respiratory burst activity, and ability 
for bacterial killing are seriously compromised. Accumulating evidence suggests that excessive 
production of C5a in sepsis may contribute to the loss of C5a binding on neutrophils, decreased 
chemotactic responsiveness, defective oxidative burst, and impaired bacteriocidal activity (7, 27, 
28, 37). Blockade of C5a and its counter partner C5aR improves the outcome of septic animals, 
underscoring the importance of C5a-C5aR signaling in the innate immunity (7, 22). The crucial 
role of C5aR signaling was directly revealed by using a whole blood model of inflammation 
(25). Blockade of C5a or C5aR drastically reduced E. coli-induced blood neutrophil oxidative 
burst and completely abolished opsonization and phagocytosis (25). It is well known that 
neutrophils quickly dash into a hyperactive stage after onset of sepsis, which may be attributable 
to multiorgan failure (26, 38–40). Thus, interception of C5a-C5aR pathway in sepsis may limit 
neutrophil-mediated tissue injury, resulting in a beneficial outcome. We here suggest another 
possibility for beneficial intervention, namely the preservation of neutrophil function at the late 
stage of sepsis. 
C5aR on neutrophils serves as a powerful tool for clearance of excessive circulating C5a (33), 
perhaps to attenuate the inflammatory responses. Previous studies have suggested that, after 
binding of C5a to C5aR on neutrophils, the ligand/receptor complex is rapidly internalized, with 
C5aR being recycled to the cell surface (32, 41, 42). In LPS-induced endotoxic shock, binding of 
125I-C5a to neutrophils was significantly decreased, suggestive of down-regulation of C5aR (43). 
However, recent studies show that C5a can also bind with high affinity to a newly identified 
receptor, C5L2, which appears to be expressed in various cell types including neutrophils (44-
46). Such findings imply the limited validity of data derived from measurement of C5aR using 
binding of 125I- or fluorescein-labeled C5a. In the current study, by direct detection of C5aR with 
anti-C5aR antibody, we were able to observe the dynamic pattern of C5aR expression on 
 neutrophils in vivo during sepsis. C5aR on neutrophils was internalized at an early stage of 
sepsis (<24 h), and its re-expression could be detected on the cell surface >36 h after CLP (Fig. 
1A). The absence of changes in protein and mRNA levels in neutrophils at various time points of 
sepsis suggests that the re-expression of C5aR may be due, at least in part, to C5aR recycling. In 
striking contrast, during CLP-induced sepsis C5aR mRNA and protein levels were up-regulated 
in various organs, implying that the expression of C5aR on neutrophils may differ from that 
found in organs (22). The pattern of C5aR expression on neutrophils is perfectly concordant with 
the C5a binding curve during sepsis (28), indicating that the number of C5aR sites is critical for 
C5a binding to neutrophils. A rapid decrease in C5aR content on neutrophils was, at least in part, 
caused by systemically appearing C5a, because blockade of C5a significantly preserved C5aR 
content on blood neutrophils (Fig. 1B). It is possible that other inflammatory mediators that 
cause down-regulation of C5aR may also exist in the circulation during sepsis. 
Decreased surface content of C5aR on neutrophils has been seen in critically ill and anergic 
septic patients and in HIV patients (29, 47, 48). In the latter group, decreased level of C5aR on 
neutrophils was associated with reduced C5a-induced chemotactic responses and elevated 
peripheral levels of C5a des Arg (48). Similarly, septic neutrophils displayed transiently 
diminished C5aR content and a concomitant decrease in C5a-induced chemotaxis. There were 
also decreased levels of IL-8 receptors (CXC R1 and CXC R2) on septic neutrophils; however, 
no change was observed in chemotaxis to IL-8 (29). As seen in the same study, IL-8 receptors 
but not C5aR gene expression decreased in parallel to receptor down-regulation. These data 
highlight the differences between C5aR and other G-protein coupled chemokine receptors with 
respect to the mechanism of down-regulation and functional responses. C5aR expression was 
shown to be regulated in a manner that differed from fMLP receptor, CR1, CR3, and Fc 
receptors (32, 49). In contrast to C5aR, fMLP receptor levels increased on neutrophils in humans 
with sepsis (40, 50). Upon stimulation of their ligands, although both receptors undergo an 
internalization independent of arrestin, dynamin, and clathrin [the internalization machinery that 
is utilized by the β2-adrenergic receptor (β2AR)] (42), re-expression of fMLP receptor is 
predominantly regulated by granule motion, whereas C5aR employs a different, not yet 
specified, mechanism (32, 50). 
At 24 h after the onset of sepsis, almost all the C5aR on neutrophils internalized, as demonstrated 
by a very low level of anti-C5aR binding and unresponsiveness to 100 nM PMA (Fig. 1A and 
Fig. 3A). Soon after this time point, survival curve dropped steeply (Fig. 4A). Presumably, all 
deceased animals did not get a chance to march into a phase in which C5aR content and 
functions of neutrophils were recovering. At the late stage of sepsis (>24 h), C5aR on septic 
neutrophils started to undergo a functional recovery, as reflected by increased content of C5aR, 
associated with enhanced ROS production as well as chemotaxis. It should be pointed out that a 
uniform pattern of C5aR expression with a single peak was observed at all time points of CLP by 
using flow cytometry analysis (data not shown), representing the whole neutrophil population 
with homogeneous C5aR levels. We have previously shown that anti-C5a treatment significantly 
preserves H2O2 production and chemotactic activity of neutrophils in sepsis (7, 28), suggesting a 
potential role of low levels of C5aR in neutrophil dysfunction. Thus, we were able to establish a 
linkage between C5aR content on neutrophils and their functional capability, in response to C5a, 
to migrate toward the sites of inflammation and to fight bacterial infection during sepsis. 
Furthermore, there was a positive correlation between the level of C5aR re-expression on septic 
neutrophils and survival of individual animals. The correlation was such that all animals with 
 C5aR levels higher than the overall median at 36 h survived, whereas out of the animals with 
C5aR levels lower than the median 67% died within the next 3 days. 
Based on these findings, we postulate that higher levels of C5aR on neutrophils at the late stage 
of sepsis assemble an efficient defense system for bacterial killing, resulting in a positive 
outcome of septic animals. Most of the clinical trials for sepsis that targeted an attenuation of the 
inflammatory response failed (51). It seems reasonable to use such a strategy during the early 
onset of sepsis to suppress the overwhelming inflammatory reaction in a hyper-responsive phase. 
However, the pathogenesis of sepsis is a complex, dynamic course. In the case of neutrophils, it 
endures "hyperreactive," "dormant," and "recovering" stages. Our data suggest that, at the 
"dormant" or "recovering" phase, a treatment to facilitate the recovery of C5aR levels and 
neutrophil function could be a promising therapeutic strategy for sepsis. However, it can not be 
excluded that higher levels of C5aR may be due to reduced levels of mediators (e.g., C5a) that 
cause C5aR internalization during sepsis. C5aR levels on neutrophils may serve as a prognostic 
marker for the outcome in sepsis. Our present study for the first time demonstrates a linkage 
between C5aR on blood neutrophils and survival or death, showing a close correlation of innate 
immune functions of neutrophils and their content of C5aR in vivo. 
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Figure 1. A) C5aR expression on neutrophils during experimental sepsis. Whole blood samples from controls (normal 
rats) and CLP animals were stained with anti-C5aR rabbit serum or preimmune serum, and C5aR content on blood 
neutrophils was evaluated by flow cytometric analysis at the times indicated. B) Effect of C5a blockade on C5aR 
expression in sepsis. C5a was blocked by an intravenous injection of 500 µg anti-C5a rabbit IgG immediately after the 
onset of CLP. Control animals were subjected to sham surgery. C5aR content on blood neutrophils was assessed 12 h after 
CLP. Values are means ± SE (n=5). 
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Figure 2. Internalization of C5aR on neutrophils in sepsis. Neutrophils were isolated from whole blood 0, 24, and 48 h 
after CLP. Neutrophils from normal rats (0 h) served as control cells. A) C5aR protein level was evaluated by Western-blot 
analysis of the whole cell lysates; the figures are results from 4 separate and independent experiments. B) RT-PCR was 
used to assess C5aR mRNA expression in control and septic neutrophils; the figures are results from 3 separate 
experiments. C) C5aR translocation was visualized by confocal microscopy analysis; the figures are results from 2 separate 
experiments. 
Fig. 3 
 
 
 
Figure 3. Influence of C5aR levels on the functional responses of neutrophils. Neutrophils were isolated from whole 
blood 0, 24, and 48 h after CLP. A) Control and septic neutrophils were treated with 100 nM PMA, and PMA-induced 
internalization was evaluated by flow cytometry analysis. B) Chemotactic responses of control and septic neutrophils to 10 
nM C5a were determined by Boyden's chemotaxis assay. C) Oxidative burst activity was monitored by conversion of 
dichlorofluorescin to DCF as a measure of ROS production. *P < 0.05, **P < 0.01 compared with neutrophils in the same 
group in A and C, and compared with septic neutrophils (24 h CLP) in B. For each vertical bar,  n = 4. 
Fig. 4 
 
 
 
Figure 4. Correlation of C5aR levels on neutrophils with survival. A) Thirty-seven rats were subjected to CLP 
procedure, and a survival curve was obtained over a 7 day interval. Blood samples were taken from tail veins 36 h after 
CLP, and C5aR levels were evaluated by flow cytometry analysis. B) Based on the median, the animals were divided into 
two groups: animals with neutrophil C5aR levels higher than median (HIGH) and animals with neutrophil C5aR levels 
lower than median (LOW). C) Survival of animals from these 2 groups was monitored. 
